We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Human hand holding a variety of AI icons.
Industry Insight

The Ethical Implications of AI in Scientific Publishing

As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Small molecule closeup
Industry Insight

Confident Metabolite Identification for Meaningful Results in Multiomics Analyses

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.
Human hand holding a digital globe representing connectivity and digitization.
Industry Insight

Exploring Key Challenges in Life Science R&D

Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.
Illustration of a heart being bioprinted
Industry Insight

Human Tissue-Based Materials for 3D Bioprinting

Technology Networks spoke to Dr. Jasper Van Hoorick to learn more about the future of bioprinting, the benefits of animal-free bioinks and the development of human tissue-based bioinks.
Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
A globe sitting among leaves
Industry Insight

Global Sustainability: Lab Goals, Actions and Measuring Success

Scientists around the world are increasingly aware of the environmental footprint of their laboratories, and many are adjusting the way they work day-to-day to offset this impact. In this Industry Insights interview, Agilent's Dr. Michael Frank discusses the safety and efficiency considerations that are fundamentally linked to sustainability and considers why more labs aren’t utilizing consulting services to help them achieve their sustainability goals.
A laboratory flask made from foliage.
Industry Insight

A Spotlight on Sustainability in Pharma and Biopharma

How can the industry as a whole address sustainability issues? What are the key needs and goals of pharma and biopharma laboratories when it comes to sustainability?
A psychedelic haze.
Industry Insight

Exploring the LSD-Derivative With Potential for Treating Mood Disorders

BetterLife Pharma’s lead candidate is a non-hallucinogenic derivative of LSD that mimics the projected therapeutic properties of LSD. To learn more, we spoke with BetterLife Pharma’s chief operating officer, Dr. Hooshmand Sheshbaradaran, and head of preclinical research, Dr. Abdi Ghaffari.
Scientists in a lab working at analytical machines while others analyse data at computers in the background.
Industry Insight

A New-Generation HPLC System Has Users at Its Heart

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.
A psychedelic sun
Industry Insight

Non-Hallucinogenic Drug Inspired by Psychedelics Enters First-in-Human Study

To learn more about the progress and development of non-hallucinogenic psychedelic therapies for conditions such as depression, Technology Networks spoke with the head of research and development at Delix Therapeutics, Dr. Eliseo Salinas.
Advertisement